Dr. Agarwal's Health Care
add_icon

Dr. Agarwal's Health Care

443.25
-1.60
(-0.36%)
Market Cap
14,027.53 Cr
PE Ratio
88.46
Volume
93,803.00
Day High - Low
455.15 - 435.00
52W High-Low
568.00 - 327.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
14,027.53 Cr
EPS
2.80
PE Ratio
88.46
PB Ratio
7.36
Book Value
60.95
EBITDA
502.40
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
5.73
Debt to Equity
0.60
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Dr. Athiya Agarwal to acquire 14,41,568 shares (0.46%) from Dr. Anosh Agarwal through inter-se transfer by gift on March 13, 2026. SEBI SAST prior intimation filed for promoter group transaction.
neutral
Dr. Athiya Agarwal acquires 21,15,180 shares (0.67%) from Dr. Anosh Agarwal through gift transfer under SEBI exemption regulations on March 4, 2026.
neutral
Dr. Athiya Agarwal files prior intimation for acquiring 21,15,180 shares (0.67%) of Dr. Agarwal's Health Care Limited from Dr. Anosh Agarwal through inter-se transfer by way of gift scheduled for March 03, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,724.50
#1 1,11,066.46
59.92
#1 21,994.30
14.76
#1 1,505
36.08
62.84
1,042.00
1,01,362.57
72.54
7,184.10
#1 28.65
1,076
26.01
45.23
892.55
67,383.79
70.89
7,849.70
13.25
809
-22.38
45.70
1,755.30
35,871.45
46.38
5,575.00
12.29
790
-34.33
42.18
672.70
34,854.00
94.61
4,286.70
15.12
337
-8.85
71.15
1,110.10
29,838.42
58.12
3,771.40
12.59
481
-33.52
43.64
720.60
28,834.01
89.42
3,067.00
21.98
415
-43.89
60.07
443.25
#8 14,027.53
#8 88.46
#8 1,757.00
#2 27.64
#9 110
#1 54.61
43.06
1,199.40
12,181.01
47.18
1,566.90
17.46
244
7.26
48.64
5,289.00
11,728.31
#1 24.23
599.90
11.69
58
12.46
48.75
Growth Rate
Revenue Growth
27.64 %
Net Income Growth
15.98 %
Cash Flow Change
4.14 %
ROE
-16.84 %
ROCE
-16.24 %
EBITDA Margin (Avg.)
-3.22 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
345
369
410
429
443
476
501
507
540
Expenses
244
241
300
310
316
332
360
363
386
EBITDA
101
128
110
119
128
144
141
144
155
Operating Profit %
27 %
31 %
26 %
26 %
27 %
28 %
26 %
27 %
27 %
Depreciation
43
47
56
57
58
60
63
68
69
Interest
22
27
27
28
28
25
25
23
21
Profit Before Tax
36
54
27
33
41
59
54
54
65
Tax
13
13
9
12
13
16
16
17
21
Net Profit
23
41
18
21
28
43
38
37
44
EPS in ₹
1.94
1.39
0.43
0.45
0.73
1.04
0.95
0.94
1.07

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
752
787
1,026
1,825
2,753
3,672
Fixed Assets
551
575
702
1,293
1,746
2,523
Current Assets
146
155
228
310
759
794
Capital Work in Progress
8
11
28
99
118
153
Investments
1
0
0
34
471
264
Other Assets
193
201
296
399
418
731
Total Equity & Liabilities
752
787
1,026
1,825
2,753
3,672
Current Liabilities
146
150
206
301
400
478
Non Current Liabilities
339
438
586
865
974
1,267
Total Equity
267
199
234
659
1,380
1,927
Reserve & Surplus
242
177
206
622
1,330
1,835
Share Capital
7
7
7
8
9
32

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-56
17
44
27
-15
-8
Investing Activities
-85
-46
-155
-509
-914
-750
Operating Activities
103
99
164
233
346
360
Financing Activities
-74
-37
35
303
553
382

Share Holding

% Holding
Sept 2024
Jan 2025
Feb 2025
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
37.83 %
37.73 %
32.45 %
32.45 %
32.42 %
32.42 %
32.39 %
FIIs
0.00 %
0.00 %
56.97 %
60.62 %
59.26 %
58.13 %
58.06 %
DIIs
0.00 %
0.00 %
5.10 %
5.21 %
6.44 %
7.92 %
7.78 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
4.79 %
1.61 %
1.74 %
1.41 %
1.62 %
Others
62.17 %
62.27 %
0.69 %
0.11 %
0.14 %
0.11 %
0.15 %
No of Share Holders
29
43
2,17,289
68,696
63,021
48,168
46,554

Announcements

Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 20113 hrs ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 hrs ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 hrs ago
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 20112 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 201110 days ago
Announcement under Regulation 30 (LODR)-Credit RatingFeb 23, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 03, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 03, 2026
Grant Of Options Under Dr. AgarwalS Health Care Limited - Employees Stock Option Scheme 2022Feb 03, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressFeb 03, 2026
Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.Feb 03, 2026
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Jan 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 03, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 03, 2026
Closure of Trading WindowDec 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 19, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 17, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 31, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 31, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 30, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 30, 2025
Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025Oct 30, 2025
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025Oct 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2025
Board Meeting Intimation for Considering And Approving Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Oct 22, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 14, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Oct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 26, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-9617
-0.18%
-0.20%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-385
-0.03%
-0.03%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-341
-0.17%
-0.19%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.00%
-155
-0.06%
-0.07%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-47
-0.02%
0.00%
Invesco India Multicap Fund Direct-Growth
0.00%
0
0.00%
-2.24%
PGIM India Healthcare Fund Direct-Growth
0.00%
0
0.00%
-0.47%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.02%
Canara Robeco Conservative Hybrid Fund Direct-Growth
0.00%
0
0.00%
-0.08%
Canara Robeco Focused Fund Direct - Growth
0.00%
0
0.00%
-0.82%
Bandhan Large Cap Fund Direct-Growth
0.00%
0
0.00%
-0.63%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
-1.13%
Edelweiss Aggressive Hybrid Fund Direct - Growth
0.00%
0
0.00%
0.00%
Edelweiss Equity Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
-0.18%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.00%
0
0.00%
-3.23%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
-0.18%
Groww Nifty Total Market Index Fund Direct - Growth
0.00%
0
0.00%
-0.02%
HDFC BSE 500 Index Fund Direct - Growth
0.00%
0
0.00%
-0.03%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.18%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.00%
0
0.00%
-0.04%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.02%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
-0.18%
Invesco India Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
-0.94%
Invesco India Mid Cap Fund Direct-Growth
0.00%
0
0.00%
-0.97%

Technical Indicators

RSI(14)
Neutral
43.06
ATR(14)
Volatile
16.22
STOCH(9,6)
Neutral
56.39
STOCH RSI(14)
Neutral
43.00
MACD(12,26)
Bullish
0.36
ADX(14)
Weak Trend
15.87
UO(9)
Bearish
55.62
ROC(12)
Downtrend And Accelerating
-2.15
WillR(14)
Neutral
-42.95